Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (171-180 of 512) with videos related to

Pageof 52
Sort By:
The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Use of adjuvant chemotherapy in non-small cell lung cancer in routine practiceChristophe Massard, Pierre Tran Ba Loc, Vincent Haddad, et al.
Cancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.
Oncology (Williston Park, N.Y.)|January 20, 2005
The promise of pharmacogenomics: gemcitabine and pemetrexedRafael Rosell, Miquel Taron, Jose Miguel Sanchez, et al.
Onkologie|June 19, 2013
Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trialsAntonin Levy, Carlos Gomez-Roca, Christophe Massard, et al.
Oncotarget|January 17, 2019
<i>EGFR</i> C797S, <i>EGFR</i> T790M and <i>EGFR</i> sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Pathology, Research and Practice|May 31, 2017
EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathologyVincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Oncotarget|March 14, 2019
Correction: <i>EGFR</i> C797S, <i>EGFR</i> T790M and <i>EGFR</i> sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Clinical Pharmacology and Therapeutics|February 23, 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in CancerArthur Géraud, David Combarel, Christian Funck-Brentano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Pageof 52

Showing results (171-180 of 512) with videos related to

Sort By:
Pageof 52
The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Use of adjuvant chemotherapy in non-small cell lung cancer in routine practiceChristophe Massard, Pierre Tran Ba Loc, Vincent Haddad, et al.
Cancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.
Oncology (Williston Park, N.Y.)|January 20, 2005
The promise of pharmacogenomics: gemcitabine and pemetrexedRafael Rosell, Miquel Taron, Jose Miguel Sanchez, et al.
Onkologie|June 19, 2013
Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trialsAntonin Levy, Carlos Gomez-Roca, Christophe Massard, et al.
Oncotarget|January 17, 2019
<i>EGFR</i> C797S, <i>EGFR</i> T790M and <i>EGFR</i> sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Pathology, Research and Practice|May 31, 2017
EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathologyVincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Oncotarget|March 14, 2019
Correction: <i>EGFR</i> C797S, <i>EGFR</i> T790M and <i>EGFR</i> sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Clinical Pharmacology and Therapeutics|February 23, 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in CancerArthur Géraud, David Combarel, Christian Funck-Brentano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Pageof 52